1. Home
  2. INAB vs RETO Comparison

INAB vs RETO Comparison

Compare INAB & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • RETO
  • Stock Information
  • Founded
  • INAB 2016
  • RETO 1999
  • Country
  • INAB United States
  • RETO China
  • Employees
  • INAB N/A
  • RETO N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • RETO Multi-Sector Companies
  • Sector
  • INAB Health Care
  • RETO Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • RETO Nasdaq
  • Market Cap
  • INAB 24.0M
  • RETO 19.9M
  • IPO Year
  • INAB 2021
  • RETO 2017
  • Fundamental
  • Price
  • INAB $0.24
  • RETO $0.91
  • Analyst Decision
  • INAB Strong Buy
  • RETO
  • Analyst Count
  • INAB 3
  • RETO 0
  • Target Price
  • INAB $7.75
  • RETO N/A
  • AVG Volume (30 Days)
  • INAB 750.7K
  • RETO 42.5K
  • Earning Date
  • INAB 11-12-2024
  • RETO 12-30-2024
  • Dividend Yield
  • INAB N/A
  • RETO N/A
  • EPS Growth
  • INAB N/A
  • RETO N/A
  • EPS
  • INAB N/A
  • RETO N/A
  • Revenue
  • INAB N/A
  • RETO $3,841,142.00
  • Revenue This Year
  • INAB N/A
  • RETO N/A
  • Revenue Next Year
  • INAB N/A
  • RETO N/A
  • P/E Ratio
  • INAB N/A
  • RETO N/A
  • Revenue Growth
  • INAB N/A
  • RETO N/A
  • 52 Week Low
  • INAB $0.22
  • RETO $0.86
  • 52 Week High
  • INAB $1.93
  • RETO $5.00
  • Technical
  • Relative Strength Index (RSI)
  • INAB 38.43
  • RETO 38.99
  • Support Level
  • INAB $0.23
  • RETO $0.91
  • Resistance Level
  • INAB $0.32
  • RETO $1.10
  • Average True Range (ATR)
  • INAB 0.03
  • RETO 0.07
  • MACD
  • INAB -0.01
  • RETO -0.00
  • Stochastic Oscillator
  • INAB 10.62
  • RETO 17.43

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: